Founded in 2006 by Drs. Haifeng and Min Chen, Virovek Incorporation is the leader in adeno-associated virus (AAV) vector design, production, and purification. We have the world’s most efficient large-scale AAV manufacturing system through our innovative and proprietary technologies, which utilizes the BAC-to-AAV production system. Virovek has produced over 1,300 AAV vectors of at least 1 x 10^13 vg scale each to support research projects in 100+ university labs, non-profit institutions, and companies throughout North America, Europe, and Asia. Our mission is to provide the highest quality AAV vectors that can be used in both basic scientific research and clinical-stage drug development, allowing scientists to advance their work in the field of molecular biology. For more information, you can check out our website at www.virovek.com.
There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.
There is a registration fee to attend the conferences. To visit the exhibition is free.